Skip to content
March 25, 2026
  • Antibiotic Resistance Drives Majority of India’s Typhoid Economic Burden: Study
  • Ahmedabad Civil Hospital Crosses 1,000 Organ and Tissue Donations in Five Years
  • Sonia Gandhi Admitted to Hospital in Delhi, Condition Stable
  • 60 Batches, Including Paracetamol and Cefixime, Fail CDSCO Quality Checks
tishha_logo

Tishha News

  • Home
  • News
  • Economics
  • Technology Innovations
  • Global Healthcare
  • Expert Talks
  • Web Stories
  • Home
  • Mounjaro

Mounjaro

image 15
  • News

Novo Nordisk to Introduce Ozempic in India This Month

tishha_newsDecember 6, 2025December 6, 202505 mins

Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…

Read More
Maharashtra Pollution Control Board 62
  • News

Eli Lilly Bets Big on India’s Weight-Loss Market, IMA Warns of Drug Misuse

tishha_newsSeptember 19, 2025September 19, 202502 mins

US pharma giant Eli Lilly is preparing to expand its footprint in India’s fast-growing weight-loss drug market. After launching its…

Read More
Apollo Hospitals
  • News

Lilly and Apollo Hospitals Join Forces to Tackle Obesity and Diabetes in India

tishha_newsMay 31, 2025May 31, 202502 mins

Eli Lilly and Company (India) has announced a strategic partnership with Apollo Health and Lifestyle and Apollo HealthCo both part…

Read More
Mounjaro
  • News

Weight-Loss Drug Mounjaro Now Available in India, All You Need to Know

tishha_newsMarch 21, 2025March 21, 202505 mins

US pharmaceutical giant Eli Lilly has introduced Mounjaro (Tirzepatide) in India, following approval from the Central Drugs Standard Control Organization…

Read More
Eli Lilly
  • News

Eli Lilly’s Mounjaro Overtakes Novo Nordisk’s Wegovy in UK Market Leadership

tishha_newsDecember 13, 2024December 13, 202421 mins

Eli Lilly’s Mounjaro has emerged as the leading choice in the UK’s private obesity drug market, outperforming Novo Nordisk’s Wegovy…

Read More

Most Viewed

News
Antibiotic Resistance Drives Majority of India’s Typhoid Economic Burden: Study
A new study published in The Lancet Regional Health Southeast…
News
Ahmedabad Civil Hospital Crosses 1,000 Organ and Tissue Donations in Five Years
In a significant milestone for healthcare and organ donation awareness,…

Random

1

Antibiotic Resistance Drives Majority of India’s Typhoid Economic Burden: Study

  • News
2

Ahmedabad Civil Hospital Crosses 1,000 Organ and Tissue Donations in Five Years

  • News
3

Sonia Gandhi Admitted to Hospital in Delhi, Condition Stable

  • News
4

60 Batches, Including Paracetamol and Cefixime, Fail CDSCO Quality Checks

  • News
5

Government Bans Entry of Pharma Representatives in Public Hospitals

  • News
6

India Launches Global Study to Integrate Ayurveda with Modern TB Treatment

  • News
7

Pacific OneHealth to Invest ₹300 Cr in Micro-Hospitals to Decentralise Care in North India

  • News
8

Harish Rana, First Indian Granted Passive Euthanasia by Supreme Court, Passes Away After 13-year Ordeal

  • News
tishha_logo
TISHHA News Developed By BlazeThemes.